• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Syndromes Without a Name Bring Labs an Uphill Battle

Syndromes Without a Name Bring Labs an Uphill Battle

by Michael Schubert, PhD | Aug 29, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Which Test? Choosing the Best Approach to Diagnosing Rare Disease

Which Test? Choosing the Best Approach to Diagnosing Rare Disease

by Michael Schubert, PhD | Sep 28, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Testing Trends-dtet

Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Investigating the Cause of the 2022 Severe Acute Hepatitis Outbreak in Children

Investigating the Cause of the 2022 Severe Acute Hepatitis Outbreak in Children

by Zahraa Chorghay, PhD | May 31, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Top of the News-dtet

AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

by Glenn S. Demby | Aug 26, 2022 | News, Open Content, Special Focus-dtet

For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.

AHA Calls for Individualized Approach to Pediatric Cardiovascular Genetic Testing

AHA Calls for Individualized Approach to Pediatric Cardiovascular Genetic Testing

by Glenn S. Demby | Aug 23, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com